Skip to main navigation Skip to search Skip to main content

Will JAK1/2 inhibitors change the standard of care for myelofibrosis?

  • Sungkyunkwan University

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)241-242
Number of pages2
JournalKorean Journal of Hematology
Volume47
Issue number4
DOIs
StatePublished - 2012
Externally publishedYes

Cite this